Today’s Solutions: December 17, 2025

For too long, migraines have been a black spot in medical research. Now sufferers of the condition can have hope after a new antibody treatment developed specifically for migraine prevention has just completed Phase III human clinical trials with remarkably positive results. In the study, respondents reported a 50 percent reduction in monthly migraine days. 

Solutions News Source Print this article
More of Today's Solutions

More US states and cities are boosting minimum wages in 2026. What does it me...

BY THE OPTIMIST DAILY EDITORIAL TEAM As the federal minimum wage remains frozen at $7.25 an hour, unchanged since 2009, cities and states across ...

Read More

3 organization hacks for Type B brains that actually work

BY THE OPTIMIST DAILY EDITORIAL TEAM Scroll through any productivity blog or time-management book, and you’ll find a familiar formula: rigid routines, detailed planners, ...

Read More

An easy hack to counteract the harmful health effects of sitting all day

Humans are not designed to spend the entire day seated. Nonetheless, billions of us do it at least five days per week, as Western ...

Read More

Ensuring no pet goes hungry: The rise of pet food banks in the UK

Pete Dolan, a cat owner, recalls the tremendous help he received from Animal Food Bank Support UK, a Facebook organization that coordinates volunteer community ...

Read More